|
|
Volumn 27, Issue 3, 2009, Pages 218-219
|
|
Pfizer swallows Wyeth, validates niche buster
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACZ 885;
ATORVASTATIN;
CINRYZE;
CLOSTRIDIOPEPTIDASE A;
COMPLEMENT COMPONENT C1S INHIBITOR;
ELTROMBOPAG;
ETANERCEPT;
GEMTUZUMAB OZOGAMICIN;
INTERLEUKIN 1BETA ANTIBODY;
NPLATE;
PNEUMOCOCCUS VACCINE;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT INTERLEUKIN 11;
RILONACEPT;
ROMIPLOSTIM;
UNCLASSIFIED DRUG;
VALSARTAN;
XIAFLEX;
XYNTHA;
ACUTE GRANULOCYTIC LEUKEMIA;
ANGIONEUROTIC EDEMA;
ANKYLOSING SPONDYLITIS;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
CLOSTRIDIUM HISTOLYTICUM;
DRUG INDICATION;
DRUG INDUSTRY;
DUPUYTREN CONTRACTURE;
GOUT;
HEMOPHILIA A;
HUMAN;
HYPERTENSION;
JUVENILE RHEUMATOID ARTHRITIS;
MUCKLE WELLS SYNDROME;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PATENT;
PEYRONIE DISEASE;
PNEUMOCOCCAL INFECTION;
PRIORITY JOURNAL;
PSORIASIS;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
THROMBOCYTOPENIA;
THROMBOCYTOPENIC PURPURA;
TREATMENT INDICATION;
BIOTECHNOLOGY;
CLOSTRIDIUM HISTOLYTICUM;
COLLAGENASES;
DRUG INDUSTRY;
DUPUYTREN'S CONTRACTURE;
HUMANS;
MALE;
ORGANIZATIONAL INNOVATION;
PATENTS AS TOPIC;
PENILE INDURATION;
PRIVATE SECTOR;
HIRUNDINIDAE;
|
|
EID: 62149146034
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0309-218 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
